HOLLY STARNES: Open Payments
NPI 1104099761 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,464 in 142 payments from 26 companies in 2025. Trend: 2023 $14,553 · 2024 $18,462 · 2025 $22,464
Speaker / faculty: $15,300Travel & lodging: $3,933Food & beverage: $3,231
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 61 | $20,415 |
| ABBVIE INC. | 32 | $573 |
| ARGENX US, INC. | 2 | $230 |
| Axsome Therapeutics, Inc. | 4 | $171 |
| Eisai Inc. | 5 | $159 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| UCB, Inc. | 4 | $106 |
| Celgene Corporation | 3 | $66 |
| MDD US Operations, LLC | 2 | $65 |
| Amgen Inc. | 3 | $62 |
Products named: ULTOMIRIS, QULIPTA, UBRELVY, VYVGART, ZEPOSIA, Symbravo, Leqembi, UPLIZNA.
Industry payments across NC — which companies pay providers there.
